Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Non-Current Deffered Revenue: 2010-2024

Historic Non-Current Deffered Revenue for Cryo Cell International (CCEL) over the last 15 years, with FY2024 value amounting to $46.6 million.

  • Cryo Cell International's Non-Current Deffered Revenue rose 1027.65% to $49.8 million in Q3 2025 from the same period last year, while for Aug 2025 it was $49.8 million, marking a year-over-year increase of 1027.65%. This contributed to the annual value of $46.6 million for FY2024, which is 1303.86% up from last year.
  • Latest data reveals that Cryo Cell International reported Non-Current Deffered Revenue of $46.6 million as of FY2024, which was up 1303.86% from $41.2 million recorded in FY2023.
  • Cryo Cell International's 5-year Non-Current Deffered Revenue high stood at $46.6 million for FY2024, and its period low was $27.2 million during FY2020.
  • Over the past 5 years, Cryo Cell International's median Non-Current Deffered Revenue value was $36.0 million (recorded in 2022), while the average stood at $36.4 million.
  • Per our database at Business Quant, Cryo Cell International's Non-Current Deffered Revenue skyrocketed by 1511.1% in 2022 and then surged by 1303.86% in 2024.
  • Cryo Cell International's Non-Current Deffered Revenue (Annual) stood at $27.2 million in 2020, then increased by 14.97% to $31.3 million in 2021, then increased by 15.11% to $36.0 million in 2022, then rose by 14.41% to $41.2 million in 2023, then grew by 13.04% to $46.6 million in 2024.
  • Its Non-Current Deffered Revenue stands at $46.6 million for FY2024, versus $41.2 million for FY2023 and $36.0 million for FY2022.